We are live on
!
Find out more
WCM
Wildcat Capital Management Portfolio holdings
AUM
$229M
1-Year Est. Return
132.65%
This Fund
S&P 500
This Quarter
Est. Return
+4.72%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$265M
AUM Growth
-$22.2M
(-7.7%)
Cap. Flow
-$29.9M
Cap. Flow
% of AUM
-11.25%
Top 10 Holdings %
Top 10 Hldgs %
96.75%
Holding
29
New
7
Increased
3
Reduced
3
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NH
NantHealth, Inc
NH
|
+$3.5M |
| 2 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
+$1.13M |
| 3 |
MiMedx Group
MDXG
|
+$973K |
| 4 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$844K |
| 5 |
Intellia Therapeutics
NTLA
|
+$665K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Editas Medicine
EDIT
|
+$6.34M |
| 2 |
TACO
Del Taco Restaurants, Inc. Common Stock
TACO
|
+$3.37M |
| 3 |
Ares Capital
ARCC
|
+$2.6M |
| 4 |
New Mountain Finance
NMFC
|
+$2.27M |
| 5 |
Goldman Sachs BDC
GSBD
|
+$1.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 22.4% |
| 2 | Healthcare | 14.56% |
| 3 | Consumer Discretionary | 4.29% |
| 4 | Financials | 1.74% |
| 5 | Technology | 1.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KITE
1
DELISTED
Kite Pharma, Inc.
KITE
| $118M | 44.43% |
2,358,084
| – | – |
|
2
CoStar Group
CSGP
$11.7B
| $55.1M | 20.75% |
2,518,370
-22,350
| -0.9% | -$442K |
|
3
ImmunityBio
IBRX
$7.51B
| $28M | 10.54% |
4,495,495
| – | – |
|
|
SRNE
4
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $15.7M | 5.91% |
2,799,790
+176,257
| +7% | +$1.13M |
|
5
Hilton Worldwide
HLT
$72.1B
| $11.4M | 4.29% |
168,333
| – | – |
|
|
6
MiMedx Group
MDXG
$602M
| $8.62M | 3.25% |
1,080,365
+125,000
| +13% | +$973K |
|
7
CALL
iShares S&P 100 ETF
OEF
$20.1B
| $8.12M | 3.06% |
65,903
+55,853
| +556% | +$5.15M |
|
8
LPL Financial
LPLA
$28.3B
| $4.61M | 1.74% |
206,647
| – | – |
|
|
UNIT
9
Uniti Group
UNIT
$2.36B
| $4.36M | 1.64% |
151,000
| – | – |
|
|
NH
10
DELISTED
NantHealth, Inc
NH
| $3.01M | 1.13% |
+16,043
| New | +$3.5M |
|
11
PUT
iShares Morningstar Value ETF
ILCV
$1.32B
| $2.28M | 0.86% |
+54,328
| New | +$2.31M |
|
|
12
PUT
iShares S&P 100 ETF
OEF
$20.1B
| $2M | 0.75% |
+17,538
| New | +$1.62M |
|
|
13
Editas Medicine
EDIT
$396M
| $1.46M | 0.55% |
59,800
-187,968
| -76% | -$6.34M |
|
14
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $864K | 0.33% |
+4,126
| New | +$856K |
|
|
15
WisdomTree Japan Hedged Equity Fund
DXJ
$7.08B
| $776K | 0.29% |
+20,000
| New | +$844K |
|
16
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $669K | 0.25% |
+4,832
| New | +$637K |
|
|
17
Intellia Therapeutics
NTLA
$1.49B
| $534K | 0.2% |
+25,000
| New | +$665K |
|
|
ADVM
18
DELISTED
Adverum Biotechnologies
ADVM
| $47K | 0.02% |
1,500
-22,026
| -94% | -$995K |
|
|
19
Ares Capital
ARCC
$13.5B
| – | – |
-175,000
| Closed | -$2.6M |
|
20
Comcast
CMCSA
$85B
| – | – |
-23,670
| Closed | -$720K |
|
21
DHI Group
DHX
$182M
| – | – |
-15,605
| Closed | -$126K |
|
|
22
Goldman Sachs BDC
GSBD
$969M
| – | – |
-100,000
| Closed | -$1.96M |
|
23
Meta Platforms (Facebook)
META
$1.42T
| – | – |
-6,163
| Closed | -$703K |
|
|
24
New Mountain Finance
NMFC
$651M
| – | – |
-179,278
| Closed | -$2.27M |
|
|
25
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| – | – |
-106,800
| Closed | -$21.9M |
|
Similar funds
AFO
CNHF
GCM
CM
CSIA
AF
NIA
HFA
Wildcat Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Wildcat Capital Management held 29 positions worth $265M, down 7.7% from $288M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Wildcat Capital Management withdrew a net $29.9M in Q2 2016, closing 11 positions and reducing 3 holdings. Its most notable exit was Del Taco Restaurants, Inc. Common Stock, an estimated $3.37M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Wildcat Capital Management opened a new position in NantHealth, Inc worth $3.01M.
- Wildcat Capital Management's largest Q2 2016 buy was NantHealth, Inc: 16,043 shares worth $3.01M.
- Wildcat Capital Management added most to Sorrento Therapeutics, Inc. in Q2 2016, an estimated $1.13M increase.
- Wildcat Capital Management's biggest Q2 2016 reduction was Editas Medicine, cutting an estimated $6.34M.
- Wildcat Capital Management fully exited Del Taco Restaurants, Inc. Common Stock in Q2 2016, selling an estimated $3.37M.
- Wildcat Capital Management's ten largest holdings make up 97% of its $265M portfolio in Q2 2016.
- Wildcat Capital Management opened 7 new positions and closed 11 in Q2 2016.
- Wildcat Capital Management's portfolio value fell 7.7% quarter-over-quarter to $265M.
Based on Wildcat Capital Management's 13F filing for Q2 2016, filed 11 Aug 2016.